Emerg Infect DisEmerging Infect. DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention3367356C1-111110.3201/eid1111.C11111CorrectionCorrectionCorrection, Vol. 11, No. 8Correction, Vol. 11, No. 8Address for correspondence: EID Editor, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop D61, Atlanta, GA 30333, USA; email: eideditor@cdc.gov112005111118081808YagupskyP , BaronEJ . Laboratory exposures to brucellae and implications for bioterrorism.Emerg Infect Dis. 2005;11:11805.Keywords: ErrataErratumCorrectionVol. 11No. 8

In "Laboratory Exposures to Brucellae and Implications for Bioterrorism" by Pablo Yagupsky and Ellen Jo Baron, an error occurred in the dosage for rifampin prophylaxis. In the second sentence of the fourth paragraph under the heading "Postexposure Prophylaxis," the correct dosage of rifampin is 600 mg once daily.

The corrected text appears in the updated article at http://wwwnc.cdc.gov/eid/article/11/8/04-1197_article.htm.

We regret any confusion this error may have caused.

Suggested Citation: Correction, Vol. 11, No. 8. Emerg Infect Dis [serial on the Internet]. 2006, May [date cited]. http://dx.doi.org/10.3201/eid1111.C11111